Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04129580 · ClinicalTrials.gov registry record · NA
reSET-O RCT (Randomized Controlled Trial)
A NA study, sponsored by Milton S. Hershey Medical Center.
- Completed
- Registry status
- NA
- Development phase
- 100
- Enrollment target
NCT04129580 is a NA study that has completed, run by Milton S. Hershey Medical Center. The registered enrollment target is 100 participants.
The verdict
NCT04129580, a NA study, has completed, sponsored by Milton S. Hershey Medical Center.
- COMPLETED
- Registry status
- NA
- Development phase
- 100 participants
- Enrollment target
Study Summary
This randomized controlled trial research study will be evaluating an app, reSET-O, owned by Pear Therapeutics, Inc., to evaluate treatment retention rates in individuals with opioid use disorder after initiating medication assisted treatment.
Interventions
- DEVICE reSET-O app
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 100 participants |
| Start Date | 2020-09-15 |
| Est. Completion | 2024-09-19 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT04129580
The ClinicalTrials.gov registry entry for NCT04129580 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 100 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Milton S. Hershey Medical Center, which has 396 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which reSET-O app is the first listed.
NCT04129580 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT04129580 about?
NCT04129580 is a clinical study titled "reSET-O RCT (Randomized Controlled Trial)". This randomized controlled trial research study will be evaluating an app, reSET-O, owned by Pear Therapeutics, Inc., to evaluate treatment retention rates in individuals with opioid use disorder after initiating medication assisted treatment.
What is the current status of trial NCT04129580?
This trial is currently completed. It is a NA study. The enrollment target is 100 participants. The study started on 2020-09-15. Estimated completion is 2024-09-19.
What interventions are being tested in trial NCT04129580?
The interventions under investigation include: reSET-O app (DEVICE).
Who is sponsoring clinical trial NCT04129580?
This trial is sponsored by Milton S. Hershey Medical Center, which has 396 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.